Product Name
Myosin Light Chain Kinase (MYLK), Recombinant Protein
Popular Item
Full Product Name
Recombinant Myosin Light Chain Kinase (MYLK)
Product Gene Name
MYLK recombinant protein
[Similar Products]
Matching Pairs
Unconjugated
Antibody: Myosin Light Chain Kinase (MYLK) (MBS2005295)
Immunogen: Myosin Light Chain Kinase (MYLK) (MBS2010288)
Matching Pairs
APC-CY7 Conjugated Antibody: Myosin Light Chain Kinase (MYLK) (MBS2051636)
Immunogen: Myosin Light Chain Kinase (MYLK) (MBS2010288)
Matching Pairs
PE Conjugated Antibody: Myosin Light Chain Kinase (MYLK) (MBS2051637)
Immunogen: Myosin Light Chain Kinase (MYLK) (MBS2010288)
Matching Pairs
APC Conjugated Antibody: Myosin Light Chain Kinase (MYLK) (MBS2051638)
Immunogen: Myosin Light Chain Kinase (MYLK) (MBS2010288)
Matching Pairs
Cy3 Conjugated Antibody: Myosin Light Chain Kinase (MYLK) (MBS2051639)
Immunogen: Myosin Light Chain Kinase (MYLK) (MBS2010288)
Matching Pairs
FITC Conjugated Antibody: Myosin Light Chain Kinase (MYLK) (MBS2051640)
Immunogen: Myosin Light Chain Kinase (MYLK) (MBS2010288)
Matching Pairs
HRP Conjugated Antibody: Myosin Light Chain Kinase (MYLK) (MBS2051641)
Immunogen: Myosin Light Chain Kinase (MYLK) (MBS2010288)
Matching Pairs
Biotin Conjugated Antibody: Myosin Light Chain Kinase (MYLK) (MBS2092895)
Immunogen: Myosin Light Chain Kinase (MYLK) (MBS2010288)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Sequence
FMGDNDNETL ANVTSATWDF DDEAFDEISD DAKDFISNLL KKDMKNRLDC TQCLQHPWLM KDTKNMEAKK LSKDRMKKYM ARRKWQKTGN AVRAIGRLSS MAMISGLSGR KSSTGSPTSP LNAEKLESEE DVSQAFLEAV AEEKPHVKPY FSKTIRDLEV VEGSAARFDC KIEGYPDPEV VWFKDDQSIR ESRHFQIDYD EDGNCSLIIS DVCGDDD
Chromosome Location
Chromosome: 3; NC_000003.11 (123331143..123603149, complement). Location: 3q21
3D Structure
ModBase 3D Structure for Q15746
Purity/Purification
> 95%
Form/Format
Supplied as lyophilized form in 20mM Tris, 150mM NaCl, pH 8.0, containing 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose and preservative.
Organism
Homo sapiens (Human)
Expression System
Prokaryotic expression
Subcellular Location
Cytoplasm. Cell projection, lamellipodium. Cleavage furrow. Cytoskeleton
Tags
Two N-terminal Tags, His-tag and GST-tag.
Endotoxin Level
<1.0EU per 1ug (determined by the LAL method)
Predicted Isoelectric Point
4.8
Reconstitution
Reconstitute in sterile PBS, pH7.2-pH7.4.
Preparation and Storage
Avoid repeated freeze/thaw cycles. Store at 2-8 degree C for one month. Aliquot and store at -80 degree C for 12 months.
Stability Test: The thermal stability is described by the loss rate of the targetprotein. The loss rate was determined by accelerated thermal degradation test,that is, incubate the protein at 37 degree C for 48h, and no obvious degradation andprecipitation were observed. (Referring from China Biological Products Standard,which was calculated by the Arrhenius equation.) The loss of this protein is lessthan 5% within the expiration date under appropriate storage condition.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.
Other Notes
Small volumes of MYLK recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Applications Tested/Suitable for MYLK recombinant protein
SDS-PAGE, Western Blot (WB), ELISA (EIA), Immunoprecipitation (IP)
SDS-Page of MYLK recombinant protein
NCBI/Uniprot data below describe general gene information for MYLK. It may not necessarily be applicable to this product.
NCBI Accession #
NP_444253.3
[Other Products]
NCBI GenBank Nucleotide #
NM_053025.3
[Other Products]
UniProt Primary Accession #
Q15746
[Other Products]
UniProt Secondary Accession #
O95796; O95797; O95798; O95799; Q14844; Q16794; Q3ZCP9; Q5MY99; Q5MYA0; Q7Z4J0; Q9C0L5[Other Products]
UniProt Related Accession #
Q15746[Other Products]
NCBI Official Full Name
myosin light chain kinase, smooth muscle isoform 1
NCBI Official Synonym Full Names
myosin light chain kinase
NCBI Official Symbol
MYLK??[Similar Products]
NCBI Official Synonym Symbols
KRP; AAT7; MLCK; MLCK1; MYLK1; smMLCK; MLCK108; MLCK210; MSTP083
??[Similar Products]
NCBI Protein Information
myosin light chain kinase, smooth muscle; telokin; kinase-related protein; myosin, light polypeptide kinase; smooth muscle myosin light chain kinase
UniProt Protein Name
Myosin light chain kinase, smooth muscle
UniProt Synonym Protein Names
Kinase-related protein; KRP; Telokin
Protein Family
Myosin light chain kinase
UniProt Gene Name
MYLK??[Similar Products]
UniProt Synonym Gene Names
MLCK; MLCK1; MYLK1; MLCK; smMLCK; KRP??[Similar Products]
UniProt Entry Name
MYLK_HUMAN
NCBI Summary for MYLK
This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts. [provided by RefSeq, Jul 2008]
UniProt Comments for MYLK
smMLCK: Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activity. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA- dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Responsible for high proliferative ability of breast cancer cells through anti-apoptosis. Defects in MYLK are the cause of familial aortic aneurysm thoracic type 7 (AAT7). AAT7 is a disease characterized by permanent dilation of the thoracic aorta usually due to degenerative changes in the aortic wall. It is primarily associated with a characteristic histologic appearance known as 'medial necrosis' or 'Erdheim cystic medial necrosis' in which there is degeneration and fragmentation of elastic fibers, loss of smooth muscle cells, and an accumulation of basophilic ground substance. Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. 8 isoforms of the human protein are produced by alternative splicing.
Protein type: Protein kinase, CAMK; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.18; Kinase, protein; CAMK group; MLCK family
Chromosomal Location of Human Ortholog: 3q21
Cellular Component: lamellipodium; cytoplasm; stress fiber; intercellular junction; cytosol; cleavage furrow
Molecular Function: calmodulin binding; protein binding; calmodulin-dependent protein kinase activity; metal ion binding; actin binding; ATP binding; myosin light chain kinase activity
Biological Process: tonic smooth muscle contraction; smooth muscle contraction; muscle contraction; actin filament organization; bleb formation; positive regulation of calcium ion transport; protein amino acid phosphorylation; positive regulation of cell migration
Disease: Aortic Aneurysm, Familial Thoracic 7
Research Articles on MYLK
1. Increased human lung endothelial cell expression of MYLK by bioactive agonists (excessive mechanical stress, TNF-alpha) is regulated in part by specific miRNAs (miR-374a, miR-374b, miR-520c-3p, and miR-1290).
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.